Traders purchased shares of UnitedHealth Group Inc (NYSE:UNH) on weakness during trading hours on Thursday after an insider sold shares in the company. $330.97 million flowed into the stock on the tick-up and $191.63 million flowed out of the stock on the tick-down, for a money net flow of $139.34 million into the stock. Of all equities tracked, UnitedHealth Group had the 6th highest net in-flow for the day. UnitedHealth Group traded down ($1.56) for the day and closed at $235.22Specifically, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The disclosure for this sale can be found here. In the last three months, insiders have sold 53,853 shares of company stock worth $12,358,508. Corporate insiders own 0.89% of the company’s stock.
UNH has been the subject of a number of research analyst reports. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 27th. Cantor Fitzgerald upped their price objective on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Evercore ISI restated an “outperform” rating and set a $255.00 price objective (up from $235.00) on shares of UnitedHealth Group in a report on Friday, January 12th. Wells Fargo & Co restated an “outperform” rating and set a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, December 7th. Two equities research analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $243.22.
The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The stock has a market cap of $224,200.00, a PE ratio of 21.65, a P/E/G ratio of 1.38 and a beta of 0.70.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, topping the consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same quarter last year, the company posted $2.11 earnings per share. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. research analysts expect that UnitedHealth Group Inc will post 12.51 EPS for the current year.
Hedge funds have recently modified their holdings of the company. Exane Derivatives lifted its holdings in UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after acquiring an additional 460 shares during the last quarter. Blue Chip Partners Inc. bought a new position in UnitedHealth Group in the second quarter worth about $110,000. Bruderman Asset Management LLC bought a new position in UnitedHealth Group in the second quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. Finally, BDO Wealth Advisors LLC bought a new position in UnitedHealth Group in the second quarter worth about $121,000. 86.21% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This news story was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright law. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/03/traders-buy-shares-of-unitedhealth-group-unh-on-weakness-on-insider-selling.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.